Daniel Aston
Publication Activity (10 Years)
Years Active: 2022-2024
Publications (10 Years): 8
Publications (10 Years): 8
Publications
- Bryan Reidy, Daniel Aston, Daniel Sitaranjan, Ibrahim Talal Fazmin, Martin Muir, Jason Ali, Ravi De Silva, Florian Falter
- Bryan Reidy, Daniel Aston, Daniel Sitaranjan, Ibrahim Talal Fazmin, Martin Muir, Jason Ali, Ravi De Silva, Florian Falter
- Bryan Reidy, Daniel Aston, Daniel Sitaranjan, Ibrahim Talal Fazmin, Martin Muir, Jason Ali, Ravi De Silva, Florian Falter
- Bryan Reidy, Daniel Aston, Daniel Sitaranjan, Ibrahim Talal Fazmin, Martin Muir, Jason Ali, Ravi De Silva, Florian Falter
- Daniel Aston, Daniel Zeloof, Florian Falter
- Daniel Aston, Martin Besser, Ben Goddard, Nicholas Maggs, Hassan Ahmed, Florian FalterWhole-blood Point-of-Care Activated Partial Thromboplastin Time Ratio (APR) is not Accurate Enough to Monitor Heparin Therapy in Patients with Severe Respiratory Failure Secondary to SARS-Cov-2 Infection Supported with Veno-Venous Extracorporeal Membrane Oxygenation (VV-ECMO). Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 28 (2022)
- Daniel Aston, Martin Besser, Ben Goddard, Nicholas Maggs, Hassan Ahmed, Florian FalterWhole-blood Point-of-Care Activated Partial Thromboplastin Time Ratio (APR) is not Accurate Enough to Monitor Heparin Therapy in Patients with Severe Respiratory Failure Secondary to SARS-Cov-2 Infection Supported with Veno-Venous Extracorporeal Membrane Oxygenation (VV-ECMO). Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 28 (2022)
- Daniel Aston, Martin Besser, Ben Goddard, Nicholas Maggs, Hassan Ahmed, Florian FalterWhole-blood Point-of-Care Activated Partial Thromboplastin Time Ratio (APR) is not Accurate Enough to Monitor Heparin Therapy in Patients with Severe Respiratory Failure Secondary to SARS-Cov-2 Infection Supported with Veno-Venous Extracorporeal Membrane Oxygenation (VV-ECMO). Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 28 (2022)